Avotermin for Scar Improvement following Scar Revision Surgery: A Randomized, Double-Blind, Within-Patient, Placebo-Controlled, Phase II Clinical Trial

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Plastic and Reconstructive Surgery

• Publication date

  2011-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/PRS.0b013e318217429bPMID 21701333
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Scar-Improving Efficacy of Avotermin Administered into the Wound Margins of Skin Incisions as Evaluated by a Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Trial

  2010cited by this paper
• Therapeutic Improvement of Scarring: Mechanisms of Scarless and Scar-Forming Healing and Approaches to the Discovery of New Treatments

  2010cited by this paper
• Insights into Patient and Clinician Concerns about Scar Appearance: Semiquantitative Structured Surveys

  2009cited by this paper
• Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies.

  2009cited by this paper
• Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFβ3): from laboratory discovery to clinical pharmaceutical

  2008cited by this paper
• New therapeutics for the prevention and reduction of scarring.

  2008cited by this paper
• Visual Analogue Scale Scoring and Ranking: A Suitable and Sensitive Method for Assessing Scar Quality?

  2006cited by this paper
• Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.

  2004cited by this paper
• Skin scarring

  2003cited by this paper
• A New Quantitative Scale for Clinical Scar Assessment

  1998cited by this paper
• Transforming growth factor beta s and wound healing.

  1997cited by this paper
• Transforming growth factor βs and wound healing

  1997cited by this paper
• Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring.

  1995cited by this paper

• Fibroblast Lineage Switching as the Developmental Origin of Scarring and Target for Regenerative Healing

  2026cites this paper
• Advances in vesicular nanocarrier-mediated therapies for hypertrophic scars: mechanistic insights, preclinical evidence and clinical perspectives.

  2026cites this paper
• Topical Salbutamol Cutaneous Gel Is Safe in a Double-Blind, Placebo-Controlled, Randomized Trial of Scarring from Sutured Wound Margins on the Arms of Healthy Human Volunteers

  2025influential citation
• Anti-Fibrotic Properties of a Decellularized Extracellular Matrix Scaffold from Porcine Small Intestinal Submucosa in Normal Human and Keloid Fibroblasts

  2025cites this paper
• Orofacial cleft repair: A clinical model for studying genetic contribution to scar severity.

  2025cites this paper
• Fibrosis mechanisms and updates in potential therapeutic targets in systemic sclerosis.

  2025cites this paper
• A Dose-Dependent Study Examining Dexmedetomidine’s Possible Effects Against Oxidative, Fibrotic, and Apoptotic Damage Induced by Radiation Exposure in Spleen Tissue

  2025cites this paper
• Fibrostenosing Crohn’s Disease: Pathogenetic Mechanisms and New Therapeutic Horizons

  2024cites this paper
• Effects of Bone Marrow Sparing and TGF-β3 Treatment in Total Body Irradiation of C57BL/6J Mice

  2024cites this paper
• Bioactive peptides and proteins for tissue repair: microenvironment modulation, rational delivery, and clinical potential

  2024cites this paper
• TGF-β signaling in health, disease and therapeutics

  2024cites this paper
• Fetal Skin Wound Healing: Key Extracellular Matrix Components and Regulators in Scarless Healing.

  2024cites this paper
• MiR-141-3p-Functionalized Exosomes Loaded in Dissolvable Microneedle Arrays for Hypertrophic Scar Treatment.

  2023cites this paper
• Lipids of Platelet-Rich Fibrin Reduce the Inflammatory Response in Mesenchymal Cells and Macrophages

  2023influential citation
• A Retrospective Self-Controlled Study Evaluating the Prophylactic Effects of CACIPLIQ20 on Postsurgical Scars

  2023cites this paper
• The Role of TGF-β3 in Radiation Response

  2023cites this paper
• Positive Feedback Loops between Fibroblasts and the Mechanical Environment Contribute to Dermal Fibrosis.

  2023cites this paper
• TGF-β3 increases the severity of radiation-induced oral mucositis and salivary gland fibrosis in a mouse model

  2023cites this paper
• Adult skin fibroblast state change in murine wound healing

  2023cites this paper
• Epithelial-Mesenchymal Interaction in Hair Regeneration and Skin Wound Healing

  2022cites this paper
• Growth Factor and Cytokine Delivery Systems for Wound Healing.

  2022cites this paper
• Is the future scarless? – Fibroblasts as targets for scarless wound healing: a narrative review

  2022cites this paper
• Inflammation in Wound Healing and Pathological Scarring

  2022cites this paper
• Effect of peripheral iridectomy on VEGF-A and TGF-β levels in rabbit aqueous humour

  2022cites this paper
• Update on management of keloid and hypertrophic scars: A systemic review

  2021cites this paper
• Development of Anti-fibrotic Therapy in Stricturing Crohn's Disease: Lessons from Randomized Trials in Other Fibrotic Diseases.

  2021cites this paper
• The Biology of Extracellular Matrix Proteins in Hypertrophic Scarring

  2021cites this paper
• Prevention and management of scarring after thermal injury

  2021cites this paper
• Pharmaceutical Prophylaxis of Scarring with Emphasis on Burns: A Review of Preclinical and Clinical Studies

  2021cites this paper
• Approaches for Regenerative Healing of Cutaneous Wound with an Emphasis on Strategies Activating the Wnt/β-Catenin Pathway

  2021cites this paper
• FAK Inhibition Attenuates Corneal Fibroblast Differentiation In Vitro

  2021cites this paper
• Scar tissue prevention and revision - introduction to a special issue

  2021cites this paper
• Current concepts on how to optimise skin needling 2020: A personal experience

  2020influential citation
• Role of TGF-β in Skin Chronic Wounds: A Keratinocyte Perspective

  2020cites this paper
• Application of 3D Printed Models of Complex Hypertrophic Scars for Preoperative Evaluation and Surgical Planning

  2020cites this paper
• The Role of Cytokines in Modulating Vocal Fold Fibrosis: A Contemporary Review

  2020cites this paper
• Pharmacological Treatment of Fibrosis: a Systematic Review of Clinical Trials

  2020cites this paper
• Current and Emerging Topical Scar Mitigation Therapies for Craniofacial Burn Wound Healing

  2020influential citation
• Advancements in the Delivery of Growth Factors and Cytokines for the Treatment of Cutaneous Wound Indications

  2020cites this paper
• New Drugs for Scar Treatment

  2020cites this paper
• Scarless Wound Healing

  2019cites this paper
• Fibrosis Mediators in the Colonic Mucosa of Acute and Healed Ulcerative Colitis

  2019cites this paper
• Keloids – an extensive review in the light of recent literature

  2019cites this paper
• Skin tissue regeneration for burn injury

  2019cites this paper
• Regeneration of Dermis: Scarring and Cells Involved

  2019cites this paper
• The Spectrum of Scarring in Craniofacial Wound Repair

  2019cites this paper
• Current and upcoming therapies to modulate skin scarring and fibrosis.

  2019cites this paper
• Therapeutic potential of endogenous stem cells and cellular factors for scar-free skin regeneration.

  2019cites this paper
• Cytokines and Growth Factors.

  2019cites this paper
• Prevention of Recurrences in Dupuytren’s Contracture: Are We in the Right Side?

  2019cites this paper
• Fibroblasts and wound healing: an update.

  2018cites this paper
• Safety and Efficacy of a Scar Cream Consisting of Highly Selective Growth Factors Within a Silicone Cream Matrix: A Double-Blinded, Randomized, Multicenter Study

  2018cites this paper
• Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids

  2018cites this paper
• Genetically‐modified bone mesenchymal stem cells with TGF‐&bgr;3 improve wound healing and reduce scar tissue formation in a rabbit model

  2018cites this paper
• Scarless wound healing: Transitioning from fetal research to regenerative healing

  2018cites this paper
• Advancements in Regenerative Strategies Through the Continuum of Burn Care

  2018cites this paper
• Multiple growth factor delivery for skin tissue engineering applications

  2017cites this paper
• PDGFRα Is a Key Regulator of T1 and T3's Differential Effect on SMA Expression in Human Corneal Fibroblasts

  2017cites this paper
• Current perspectives on biological approaches for osteoarthritis

  2017cites this paper
• Soft Tissue Principles to Minimize Scarring: An Overview.

  2017cites this paper
• Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment

  2017cites this paper
• Minimizing Skin Scarring through Biomaterial Design

  2017cites this paper
• The role of TGFβ in wound healing pathologies.

  2017cites this paper
• Discussion: Identification of Key Modules and Hub Genes of Keloids with Weighted Gene Coexpression Network Analysis.

  2017cites this paper
• The effects of TGF-βs on immune responses.

  2016cites this paper
• Molecular insights on the effect of TGF-β1/-β3 in human corneal fibroblasts.

  2016cites this paper
• Scar Management in the Pediatric and Adolescent Populations

  2016cites this paper
• PLGA based drug delivery systems: Promising carriers for wound healing activity

  2016cites this paper
• Transforming growth factor beta (TGF‐β) isoforms in wound healing and fibrosis

  2016cites this paper
• Modelling wound healing

  2016cites this paper
• Signalling by Transforming Growth Factor Beta Isoforms in Wound Healing and Tissue Regeneration

  2016cites this paper
• Mechanisms, Potential Therapies, and the Role of TGF-β in the Formation of Scars

  2015cites this paper
• Is Avotermin Safe and Effective Treatment for Scar Improvement in Healthy Males and Females

  2015cites this paper
• Microstructural and molecular considerations in the treatment of scars with ablative fractional lasers.

  2015cites this paper
• Aetna considers TransCyte experimental and investigational for all other indications because its effe for indications other than the ones listed above has not been established.

  2015cites this paper
• Review papers Some molecular aspects of the fibroproliferative process in keloids

  2015cites this paper
• Wound healing and skin regeneration.

  2015cites this paper
• Effect of P144® (Anti-TGF-β) in an “In Vivo” Human Hypertrophic Scar Model in Nude Mice

  2015cites this paper
• Regenerative Skin Wound Healing in Mammals: State-of-the-Art on Growth Factor and Stem Cell Based Treatments

  2015cites this paper
• Involvement of transforming growth factor-β3 and betaglycan in the cytoarchitecture of postoperative omental adhesions.

  2014cites this paper
• Scar prevention and remodeling: a review of the medical, surgical, topical and light treatment approaches

  2014cites this paper
• Regulating Inflammation Using Acid-Responsive Electrospun Fibrous Scaffolds for Skin Scarless Healing

  2014cites this paper
• Topical and Intralesional Therapies

  2014cites this paper
• Clinical Use of Growth Factors in the Improvement of Skin Wound Healing

  2014cites this paper
• Advances in kinase targeting: current clinical use and clinical trials.

  2014cites this paper
• Discussion: The embrace Device Significantly Decreases Scarring following Scar Revision Surgery in a Randomized Controlled Trial

  2014cites this paper
• Preliminary results of antiscarring therapy in the prevention of postendoscopic esophageal mucosectomy strictures

  2014cites this paper
• Effects of interleukin‐10 on cutaneous wounds and scars in humans of African continental ancestral origin

  2014cites this paper
• Strategies Demonstrating Efficacy in Reducing Wound Contraction In Vivo

  2013cites this paper
• Interleukin‐10 reduces scar formation in both animal and human cutaneous wounds: Results of two preclinical and phase II randomized control studies

  2013cites this paper
• Dynamics of Transforming Growth Factor Beta Signaling in Wound Healing and Scarring

  2013cites this paper
• TGF-β3 modulates the inflammatory environment and reduces scar formation following vocal fold mucosal injury in rats

  2013influential citation
• Local Anesthetics in Liposuction: Considerations for New Practice Advisory Guidelines to Improve Patient Safety

  2013cites this paper
• High blood pressure (hypertension) may influence the results of clinical trials for scar and keloid treatments.

  2013cites this paper
• Intralesional Treatment for Keloids and Hypertrophic Scars: A Review

  2013cites this paper
• A Paradigm of Fibroblast Activation and Dermal Wound Contraction to Guide the Development of Therapies for Chronic Wounds and Pathologic Scars

  2013cites this paper
• Reply: transdiaphragmatic omental harvest: a simple, efficient method for sternal wound coverage.

  2013cites this paper
• Alternatives for animal wound model systems.

  2013cites this paper
• Angiotensin-Converting Enzyme Inhibitor Enalapril Reduces Formation of Hypertrophic Scars in a Rabbit Ear Wounding Model

  2013cites this paper
• Incidence of Concomitant Airway Anomalies When Using the University of California , Los Angeles , Protocol for Neonatal Mandibular Distraction

  2013cites this paper